AG00ID90

82571-53-7 | 2-Propenoic acid, 3-[4-(1H-imidazol-1-ylmethyl)phenyl]-, (2E)-

Chemical structure of 2-Propenoic acid, 3-[4-(1H-imidazol-1-ylmethyl)phenyl]-, (2E)-, CAS 82571-53-7
AG00ID90
sdsSDS
sdsCOA

Price

$0.00

WARNING This product is not for human or veterinary use.
Request For Quotation
CAS Number 82571-53-7
Catalog Number AG00ID90(AGN-PC-0OIPT7)
Chemical Name 2-Propenoic acid, 3-[4-(1H-imidazol-1-ylmethyl)phenyl]-, (2E)-
EC Number 919-112-4
IUPAC Name (E)-3-[4-(imidazol-1-ylmethyl)phenyl]prop-2-enoic acid
InChI InChI=1S/C13H12N2O2/c16-13(17)6-5-11-1-3-12(4-2-11)9-15-8-7-14-10-15/h1-8,10H,9H2,(H,16,17)/b6-5+
InChI Key SHZKQBHERIJWAO-AATRIKPKSA-N
MDL Number MFCD12547851
Molecular Formula C13H12N2O2
Molecular Weight 228.2466
SMILES O=C(O)/C=C/C1=CC=C(CN2C=CN=C2)C=C1
UNII L256JB984D
Synonyms
3-(4-(1H-imidazol-1-ylmethyl)phenyl)-2-propenoic acid, 4-(1-imidazoylmethyl)cinnamic acid, OKY 046, OKY-046, ozagrel, ozagrel, monohydrochloride, ozagrel, monohydrochloride, (E)-isomer, sodium ozagrel, ozagrel, 82571-53-7, Ozagrel [INN], Ozagrelum [Latin], OKY 046, OKY-046, Domenan, UNII-L256JB984D, (E)-3-[4-(imidazol-1-ylmethyl)phenyl]prop-2-enoic acid, CHEMBL11662, (E)-3-(4-((1H-IMIDAZOL-1-YL)METHYL)PHENYL)ACRYLIC ACID, C13H12N2O2, L256JB984D, Ozagrel (INN), (E)-p-(Imidazol-1-ylmethyl)cinnamic acid, 2-Propenoic acid, 3-(4-(1H-imidazol-1-ylmethyl)phenyl)-, (E)-, KCT-0809, pulmoza, Ozagrelum, 3-[4-(1H-IMIDAZOL-1-YLMETHYL)PHENYL]-2E-PROPENOIC ACID, Cataclot (TN), 4-(1-imidazoylmethyl)cinnamic acid, Ozagrel,(S), Prestwick2_000979, Prestwick3_000979, 3-[4-(imidazol-1-ylmethyl)phenyl]prop-2-enoic acid, AC1NR02S, SCHEMBL4210, BSPBio_001017, BPBio1_001119, GTPL9866, OKY046, ZINC5389, 3-(4-(1H-imidazol-1-ylmethyl)phenyl)-2-propenoic acid, DTXSID6048547, CHEBI:92359, CHEBI:134938, SHZKQBHERIJWAO-AATRIKPKSA-N, HMS2089O14, HMS3649M21, BCP12147, HY-B0428, BDBM50017896, MFCD00868231, s2496, AKOS015889403, AB07569, AC-2080, CS-2534, DB12017, NCGC00025195-02, AJ-08246, AN-14330, BC209190, CC-33439, H981, SC-22625, SBI-0207081.P001, AB0013402, AB2000601, BC4304326, LS-177692, TL8005457, AB00514722, SW197369-5, 3-(4-Imidazol-1-ylmethyl-phenyl)-acrylic acid, D08327, (E)-3-(4-((1H-imidazol-1-yl)methyl)phenyl), AB00514722-10, AB00514722-12, AB00514722-13, AB00514722_14, AB00514722_15, 4-(1H-Imidazole-1-ylmethyl)benzenepropenoic acid, 571O537, A840374, C-13075, (E)-3-(4-Imidazol-1-ylmethyl-phenyl)-acrylic acid, I01-1859, Q-100843, SR-01000597793-8, BRD-K19525698-003-01-1, BRD-K53061490-003-03-0, (E)-3-[4-(1-imidazolylmethyl)phenyl]-2-propenoic acid, (2E)-3-[4-(imidazol-1-ylmethyl)phenyl]prop-2-enoic acid, (E)-3-[P-(1H-IMIDAZOL-1-YLMETHYL)PHENYL]-2-PROPENO, (2E)-3-[4-(1H-IMIDAZOL-1-YLMETHYL)PHENYL]ACRYLIC ACID, 2-propenoic acid, 3-[4-(1H-imidazol-1-ylmethyl)phenyl]-, (2E), 2-Propenoic acid, 3-[4-(1H-imidazol-1-ylmethyl)phenyl]-, (2E)-, Ozagrel sodium, Sodium ozagrel, Cataclot, Xanbon, ozagrel hydrochloride, OZAGREL HCl, ACRYLIC ACID, ozagrel, monohydrochloride, D0C7AA, D0T2IH, Ozagrel hydrochloride hydrate, CHEMBL542549, Ozagrel (ophthalmic, eye disorders), GSK610677, C13-H12-N2-O2, ACN-048761, CID5282440, ozagrel, monohydrochloride, (E)-isomer, (E)-4-(imidazol-1-ylmethyl)cinnamic acid, A4344, A10688, C034364, SR-01000597793, Ozagrel (ophthalmic, eye disorders), Kissei/ Teika, Ozagrel(OKY-046) Thromboxane A2 synthetase inhibitor, (2E)-3-[4-(1H-Imidazol-1-ylmethyl)phenyl]-2-propenoic acid, (E)-3-[4-(1H-Imidiazol-1-ylmethyl)phenyl]-2-propenic acid, (E)-3-(4-(1H-IMIDIAZOL-1-YLMETHYL)PHENYL)-2-PROPENIC ACID,

Related Research Chemicals

CERTIFICATE OF ANALYSIS
Chemical Name: Batch Number:
Chemical Structure: CAS Registry No:
Product ID:
Manufacture Date:
Storage Temperature:
Formula:
Molecular Weight:
Quantity:
Analysis Data:
Test: Result:
Conclusion: The above product meets the specifications of Angene.
Analyst:Chase
Date:
Reviewed by:Jessie
Date:
Angene International Limited